Science Explorer Back to mapMap
Discussion
Researcher · Mapi Pharma (Israel) · Israel

Nadav Bleich Kimelman

Nadav Bleich Kimelman publishes mostly in Pathology and Forensic Medicine, Genetics and Oncology, on topics such as Multiple Sclerosis Research Studies, Mesenchymal stem cell research and Tissue Engineering and Regenerative Medicine.

OpenAlex
World rank
#5,775,260
of 7,710,434 ranked researchers
Rank in Israel
#33,274
of 38,292
Works
33
Citations
239
Citations per work
7.2
h-index
5
i10-index 4Top 90% in Pathology and Forensic Medicine
Nadav Bleich Kimelman

What does Nadav Bleich Kimelman research?

Nadav Bleich Kimelman's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (9%), Pharmacology, Toxicology and Pharmaceutics (4%).

Health Sciences: 15 works · 46.3% of their workMedicine: 15 works · 46.3% of their workPathology and Forensic Medicine: 6 works · 17.9% of their workGenetics: 4 works · 13.4% of their workOncology: 3 works · 9.0% of their workSurgery: 2 works · 6.0% of their workEverything else: 13 works · 40.2% of their workLife Sciences: 4 works · 13.5% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 9.0% of their workMolecular Biology: 3 works · 9.0% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 4.5% of their workPharmaceutical Science: 1 works · 4.5% of their workTHEIR WORKNadav BleichKimelman33works
Life Sciences14%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1546.3%
  2. Everything else1340.2%
    1. Biochemistry, Genetics and Molecular Biology39.0%
    2. Pharmacology, Toxicology and Pharmaceutics14.5%
  1. 1Pathology and Forensic Medicine18% of their works
  2. 2Genetics13% of their works
  3. 3Oncology9% of their works
  4. 4Molecular Biology9% of their works
  5. 5Surgery6% of their works
  6. 6Pharmaceutical Science4% of their works

Research topics

Which keywords describe Nadav Bleich Kimelman's research?

The keywords of their largest research topics: Stromal Cells, Diagnostic Criteria, Multiple Sclerosis, Mesenchymal Stem Cells, Multipotent, Extracellular Matrix, Regenerative Medicine and Angiogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Stromal Cells112 topics
  2. Diagnostic Criteria101 topic
  3. Multiple Sclerosis101 topic
  4. Mesenchymal Stem Cells81 topic
  5. Multipotent81 topic
  6. Extracellular Matrix62 topics
  7. Regenerative Medicine62 topics
  8. Angiogenesis52 topics
  9. Drug Delivery52 topics
  10. Decellularization41 topic
  11. Organ Engineering41 topic
  12. Chitosan31 topic
  13. Fibroblast Activation Protein31 topic
  14. Nanoparticles31 topic
  15. Tumor Microenvironment31 topic
  16. Cardiovascular Outcomes21 topic
  17. Electrospinning21 topic
  18. Matrix Metalloproteinases21 topic
  19. Nanofibers21 topic
  20. Tissue Inhibitors of Metalloproteinases21 topic
  21. Type 2 Diabetes21 topic

Where does Nadav Bleich Kimelman work?

Nadav Bleich Kimelman's main affiliation in the publication record is Mapi Pharma (Israel), Israel.

How many publications and citations does Nadav Bleich Kimelman have?

OpenAlex counts 33 works and 239 citations for Nadav Bleich Kimelman, an h-index of 5, ranking #5,775,260 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nadav Bleich Kimelman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.